Mohammad Haider Khan and Muhammad Syed Ali Hamza, “Resmetirom in fatty liver disease: A promising step ahead in metabolic dysfunction-associated steatotic liver disease treatment”, J Pak Med Assoc, vol. 76, no. 06, pp. 1002–1002, May 2026.